Abstract
Patel et al. report an increased risk of intussusception after rotavirus vaccination.1 We conducted a case-series analysis2 of 151 spontaneous reports of intussusception worldwide after administration of the rotavirus vaccine RV1 (Rotarix, GlaxoSmithKline Biologicals). On the basis of a report citing the incidence of intussusception after administration of the rotavirus vaccine RotaShield (Wyeth Laboratories),3 we tested for an increased risk of intussusception 3 to 7 days after administration of the first dose. Incidence ratios were calculated for the periods 0 through 2 days (with 0 indicating the day of vaccination), 3 through 7 days, and 8 through 14 days after vaccination; days 15 through 30 constituted the reference period. To account for temporal trends in underreporting, which were assumed to be identical for the first and second doses, we divided each incidence ratio calculated after administration of the first dose by the corresponding value after the second dose.